Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-16

FDA Approved: ETHOSUXIMIDE — Original Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved Ethosuximide from Epic Pharma, LLC under an Abbreviated New Drug Application. It is approved as a generic treatment for absence seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ethosuximide (ethosuximide)

Snippet

ORIG AP for ETHOSUXIMIDE (ETHOSUXIMIDE)